Organization · Venture Capital
20/20 HealthCare Partners
20/20 HealthCare Partners is a global investment group based in Auburndale, Massachusetts, focusing on early-stage technology and life science innovations in healthcare. They provide equity financing and work closely with management to enhance product development and market penetration.
Overview
What 20/20 HealthCare Partners does
What 20/20 HealthCare Partners is
20/20 HealthCare Partners is a global investment group based in Auburndale, Massachusetts, focusing on early-stage technology and life science innovations in healthcare. They provide equity financing and work closely with management to enhance product development and market penetration.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2005
- Approximate age
- About 21 years
- Structured capabilities
- Funder
- Last reviewed
- April 22, 2026
Official channels
Find 20/20 HealthCare Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
20/20 HealthCare Partners as a funder
Investment thesis
20/20 HealthCare Partners focuses on early-stage healthcare technology and life sciences, emphasizing device and diagnostics innovation with clinical applicability.
Focus narrative
The organization invests in a diverse range of sectors within healthcare, including diagnostic imaging, medical devices, healthcare IT, biotechnology, and pharmaceuticals. 20/20 HealthCare Partners seeks extraordinary entrepreneurs with distinctive technologies, employing a flexible investment structure to capitalize on market opportunities, particularly in the life sciences industry.
Value beyond capital
20/20 HealthCare Partners adds value to its portfolio companies by leveraging its extensive network within the healthcare community, providing strategic guidance, and facilitating partnerships that enhance growth and innovation.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series A+
- Sectors
- Healthcare · Biotech · Medical Devices · Diagnostics
- Regions
- Global · North America
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 8
Portfolio context
Notable portfolio companies include: Variantyx: Specializes in whole genome sequencing (WGS) for comprehensive genomic diagnostic care. NEMDX: Develops a medical diagnostic platform for neurodegenerative diseases and oncology. Remedy Plan Therapeutics: Focuses on drugs targeting cancer stem cells. XR Health: Creates medical applications using XR technology. Corindus: A leader in robotic-assisted vascular interventions. SQZ Biotech: Develops novel cell therapies for oncology. Coagulo Medical Technologies: Offers a portable precision-medicine platform for coagulation management. UltraSPECT: Provides low dose imaging solutions.
Common questions
What to know about 20/20 HealthCare Partners
Upseed classifies 20/20 HealthCare Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 22, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.